6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

C128H128Cl6F5N31O16 — CID 161292872

IUPAC6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.COCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2c(cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n2CC(=O)N2CC(C)(F)C2)c2c1nc(C)n2C.Cn1c(CCl)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.Cn1c(CN2CCC2)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C28H29ClFN7O3.C26H26ClFN6O4.C26H26ClFN6O3.C25H23Cl2FN6O3.C23H24ClFN6O3/c1-28(30)15-36(16-28)23(38)14-37-25-19(24-21(12-31-25)33-22(34(24)2)13-35-8-3-9-35)10-20(27(37)40)26(39)32-11-17-4-6-18(29)7-5-17;1-26(28)13-33(14-26)21(35)11-34-23-17(22-19(10-29-23)31-20(12-38-3)32(22)2)8-18(25(34)37)24(36)30-9-15-4-6-16(27)7-5-15;1-14-21-22(32(4)15(2)31-21)18-9-19(24(36)29-10-16-5-7-17(27)8-6-16)25(37)34(23(18)30-14)11-20(35)33-12-26(3,28)13-33;1-25(28)12-33(13-25)20(35)11-34-22-16(21-18(10-29-22)31-19(8-26)32(21)2)7-17(24(34)37)23(36)30-9-14-3-5-15(27)6-4-14;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h4-7,10,12H,3,8-9,11,13-16H2,1-2H3,(H,32,39);4-8,10H,9,11-14H2,1-3H3,(H,30,36);5-9H,10-13H2,1-4H3,(H,29,36);3-7,10H,8-9,11-13H2,1-2H3,(H,30,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33)
InChIKeyVGOYQRFLWMHAMB-UHFFFAOYSA-N
MW2664.34 g/mol
LogP13.63
Rot. Bonds31

About 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (PubChem CID 161292872) has the molecular formula C128H128Cl6F5N31O16 and a molecular weight of 2664.34 g/mol. Its IUPAC name is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.

Molecular Properties

Compound Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
PubChem CID161292872
Molecular FormulaC128H128Cl6F5N31O16
Molecular Weight2664.34 g/mol
Exact Mass2659.82
IUPAC Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.COCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2c(cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n2CC(=O)N2CC(C)(F)C2)c2c1nc(C)n2C.Cn1c(CCl)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.Cn1c(CN2CCC2)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C28H29ClFN7O3.C26H26ClFN6O4.C26H26ClFN6O3.C25H23Cl2FN6O3.C23H24ClFN6O3/c1-28(30)15-36(16-28)23(38)14-37-25-19(24-21(12-31-25)33-22(34(24)2)13-35-8-3-9-35)10-20(27(37)40)26(39)32-11-17-4-6-18(29)7-5-17;1-26(28)13-33(14-26)21(35)11-34-23-17(22-19(10-29-23)31-20(12-38-3)32(22)2)8-18(25(34)37)24(36)30-9-15-4-6-16(27)7-5-15;1-14-21-22(32(4)15(2)31-21)18-9-19(24(36)29-10-16-5-7-17(27)8-6-16)25(37)34(23(18)30-14)11-20(35)33-12-26(3,28)13-33;1-25(28)12-33(13-25)20(35)11-34-22-16(21-18(10-29-22)31-19(8-26)32(21)2)7-17(24(34)37)23(36)30-9-14-3-5-15(27)6-4-14;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h4-7,10,12H,3,8-9,11,13-16H2,1-2H3,(H,32,39);4-8,10H,9,11-14H2,1-3H3,(H,30,36);5-9H,10-13H2,1-4H3,(H,29,36);3-7,10H,8-9,11-13H2,1-2H3,(H,30,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33)
InChIKeyVGOYQRFLWMHAMB-UHFFFAOYSA-N
XLogP13.63
TPSA543.30 Ų
H-Bond Donors7
H-Bond Acceptors37
Rotatable Bonds31
Heavy Atoms186
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002664.34
LogP ≤ 513.63
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (CID 161292872) is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.
What is the SMILES notation for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The canonical SMILES for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.COCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2c(cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n2CC(=O)N2CC(C)(F)C2)c2c1nc(C)n2C.Cn1c(CCl)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.Cn1c(CN2CCC2)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.
What is the InChIKey of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The InChIKey is VGOYQRFLWMHAMB-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29ClFN7O3.C26H26ClFN6O4.C26H26ClFN6O3.C25H23Cl2FN6O3.C23H24ClFN6O3/c1-28(30)15-36(16-28)23(38)14-37-25-19(24-21(12-31-25)33-22(34(24)2)13-35-8-3-9-35)10-20(27(37)40)26(39)32-11-17-4-6-18(29)7-5-17;1-26(28)13-33(14-26)21(35)11-34-23-17(22-19(10-29-23)31-20(12-38-3)32(22)2)8-18(25(34)37)24(36)30-9-15-4-6-16(27)7-5-15;1-14-21-22(32(4)15(2)31-21)18-9-19(24(36)29-10-16-5-7-17(27)8-6-16)25(37)34(23(18)30-14)11-20(35)33-12-26(3,28)13-33;1-25(28)12-33(13-25)20(35)11-34-22-16(21-18(10-29-22)31-19(8-26)32(21)2)7-17(24(34)37)23(36)30-9-14-3-5-15(27)6-4-14;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h4-7,10,12H,3,8-9,11,13-16H2,1-2H3,(H,32,39);4-8,10H,9,11-14H2,1-3H3,(H,30,36);5-9H,10-13H2,1-4H3,(H,29,36);3-7,10H,8-9,11-13H2,1-2H3,(H,30,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33).
What are the key properties of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide has a molecular weight of 2664.34 g/mol, XLogP of 13.63, 31 rotatable bonds, 7 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(azetidin-1-ylmethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is sourced from PubChem (CID 161292872), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).